BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results
BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results Revenue Increased 39% for the Quarter and 34% for the Year Achieves Positive Cash Flow from Operations for the Year Reaffirms Guidance for 2018 Operating Profit On March 8, 2018 BioLife Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue […]